127 related articles for article (PubMed ID: 55523)
1. A randomized pilot study comparing two regimens in the treatment of squamous cell carcinoma.
Moseley HS; Sasaki T; McConnell DB; Merhoff GC; Wilson WL; Grage TB; Wiess AJ; Fletcher WS
J Surg Oncol; 1976; 8(1):35-42. PubMed ID: 55523
[TBL] [Abstract][Full Text] [Related]
2. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
Stolinsky DC; Bull FE; Pajak TF; Bateman JR
Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
DiBella NJ; Nelson RA; Norgard MJ
Oncology; 1975; 32(2):82-5. PubMed ID: 815858
[TBL] [Abstract][Full Text] [Related]
4. CCNU and bleomycin in the treatment of cancer: a Southwest Oncology Group Study.
Hoogstraten B; Haas CD; Haut A; Talley RW; Rivkin S; Isaacs BL
Med Pediatr Oncol; 1975; 1(2):95-106. PubMed ID: 59307
[TBL] [Abstract][Full Text] [Related]
5. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
Alberto P; Barrelet L; Chapuis B; Garcia B
Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
[No Abstract] [Full Text] [Related]
6. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
Schröder M; von Heyden HW; Beyer JH; Klee M
Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
8. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
9. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin, bleomycin, and CCNU as effective induction chemotherapeutic agents in advanced squamous cell carcinoma (COG Protocol 7333).
Scarborough JP; Metter GE; Stephens Moseley H; Kraybill WG; Davenport C; Strawitz JG; Cobau CD; Golomb FM; Fletcher WS
J Surg Oncol; 1978; 10(6):501-9. PubMed ID: 83452
[TBL] [Abstract][Full Text] [Related]
11. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.
Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P
Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132
[TBL] [Abstract][Full Text] [Related]
12. Vinblastine, methotrexate, bleomycin, in the management of head and neck cancer.
Vanhaelen C; Bertrand M; De Jager R; Kenis Y
Eur J Cancer (1965); 1979 Nov; 15(11):1315-8. PubMed ID: 93540
[No Abstract] [Full Text] [Related]
13. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
Kurnick JE; White M; Ware DE; Robinson WA
Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
McMahon LJ; Jones SE; Durie BG; Salmon SE
Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213
[TBL] [Abstract][Full Text] [Related]
16. Combined chemotherapy of head and neck squamous cell carcinomas with methotrexate, bleomycin, and hydroxyurea.
Medenica R; Alberto P; Lehmann W
Cancer Chemother Pharmacol; 1981; 5(3):145-9. PubMed ID: 6170472
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
[TBL] [Abstract][Full Text] [Related]
19. CCNU-adriamycin therapy in bronchogenic carcinoma.
Trowbridge RC; Kennedy BJ; Vosika GJ
Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
[TBL] [Abstract][Full Text] [Related]
20. A trial of outpatient chemotherapy for recurrent head and neck tumors.
Huang AT; Lucas VS; Baughn SG; Cole TB
Cancer; 1980 Apr; 45(8):2038-41. PubMed ID: 6154522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]